• BG IRIS Research Client Login
logo
logo
  • Transactions
  • Services
    • Overview
    • Solutions
    • Sector expertise
    • Research
  • Insights
    • Overview
    • White Papers
    • Blog
    • Reports
    • Client Focus
  • About us
    • Overview
    • Senior Team
    • News
    • Events
  • Careers
    • Overview
    • Early careers
    • Experienced hires
    • Employee Growth Stories
  • Media
    • Press
    • Videos
  • Contact
  • Search
  • BG IRIS Research Client Login

Solutions


From raising venture capital to taking companies public, supporting acquisition strategies to advising management buy-outs or finding strategic partners, Bryan Garnier supports clients and their investors at every stage of their growth and investing journeys.​ Bryan Garnier’s holistic approach to advising clients on the full range of equity, debt and M&A transactions creates a true client-first model, building long-term relationships over the full business lifecycle.

M&A Advisory


Private Capital Solutions


Debt Solutions

Public Capital Solutions


Institutional Sales and Trading

Hide filtersShow filters
× Close

Sectors

  • (218)
  • (177)
  • (106)
  • (96)
  • (48)

Deal Type

  • (298)
  • (141)
  • (141)
  • (7)

Clear all Apply

Bryan, Garnier & Co acts as Sole Financial Advisor to Protix on its €50 million Fundraising

Bryan, Garnier & Co advises Cathay Capital, Sagard NewGen and Eurazeo on their investment in DiliTrust

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to the leading geo-analytics company Kayrros on its €40 million Series C financing from New Space Capital, Bpifrance, Opera Tech Ventures (BNP Paribas VC arm), EIB and existing shareholders

Bryan, Garnier & Co acts as Sole Financial Advisor to MNH on the sale of AKLIA to Hoppen

Bryan, Garnier & Co is proud to act as Joint Bookrunner to Cell Impact on its SEK 349m Rights Issue

Bryan, Garnier & Co acts as Sole Financial Advisor to Wandercraft on its $45 million Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor to Aquiline Capital Partners and Elyan Partners on their potential investment in Cheops Technology

Bryan, Garnier & Co acts as Sole Financial Advisor to Cleerly on its USD 43 million Series B Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor to Agronutris on its €100 million Fundraising

Bryan, Garnier & Co acts as Sole Financial Advisor and Sole Placement Agent to leading European cybersecurity company EclecticIQ on its follow-on placement with the European Investment Bank, securing the total funding to the firm of EUR 35 million over the last 12 months

Bryan, Garnier & Co acts as Sole Financial Advisor to the shareholders of CanPharma GmbH on the sale of the company to Health House International Ltd (ASX:HHI)

Bryan, Garnier & Co acts as Advisor to the Shareholders of Advania on its majority sale to Goldman Sachs funds

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 12

Bryan, Garnier & Co

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors.

CONTACT US
Latest News

  • BCI – Made in France 2025 – Hosted by Bryan, Garnier & Co
  • The Next Launch Window: What It Means for Satcoms
  • BG Growth Series – Avantium
  • Energy-Aware AI: Confronting the power-hungry reality of scaling AI
Quick links

Transactions

Insights

Senior Team

Information

Legal & Regulatory Information

Index 2025

Bryan Garnier Securities

Privacy Policy

Privacy Preference Center

Privacy Preferences

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }